| Line Item | 2022-12-31 | Y/Y |
|---|---|---|
| Revenue | $69.2M | -8.8% |
| Cost of Revenue | $45.9M | +12.5% |
| Gross Profit | $23.3M | -33.5% |
| R&D Expense | $27.9M | +30.2% |
| SG&A Expense | $41.5M | +28.5% |
| Operating Income | -$84.6M | -51.7% |
| Interest Expense | $1.1M | -37.7% |
| Pre-tax Income | -$79.3M | -10.7% |
| Income Tax | $29K |
| Line Item | 2022-12-31 | Y/Y |
|---|---|---|
| Cash & Equivalents | $11.2M | -88.2% |
| Accounts Receivable | $16.0M | +52.4% |
| Inventory | $18.5M | +3.0% |
| Current Assets | $51.3M | -62.3% |
| Total Assets | $58.1M | -58.5% |
| Current Liabilities | $66.6M | -3.6% |
| Long-term Debt | $10.4M | -37.4% |
| Line Item | 2022-12-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | -$81.4M | -100.7% |
| Capital Expenditures | $636K | -34.4% |
| Investing Cash Flow | -$1.6M | +22.5% |
| Financing Cash Flow | -$878K | -100.7% |
| Free Cash Flow | -$82.0M | -97.5% |
| -6.5% |
| Net Income | -$79.3M | -10.6% |
| EPS (Basic) | -$0.71 | +37.2% |
| EPS (Diluted) | -$0.71 | +37.2% |
| Total Liabilities |
| $68.7M |
| -19.0% |
| Stockholders' Equity | -$10.6M | -119.3% |